These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3095849

  • 1. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
    Harczy M, Maclouf J, Pradelles P, Braquet P, Borgeat P, Sirois P.
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():111-7. PubMed ID: 3095849
    [Abstract] [Full Text] [Related]

  • 2. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
    Berti F, Omini C, Rossoni G, Braquet P.
    Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
    [Abstract] [Full Text] [Related]

  • 3. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
    Lagente V, Touvay C, Randon J, Desquand S, Cirino M, Vilain B, Lefort J, Braquet P, Vargaftig BB.
    Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723
    [Abstract] [Full Text] [Related]

  • 4. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
    Desquand S, Touvay C, Randon J, Lagente V, Vilain B, Maridonneau-Parini I, Etienne A, Lefort J, Braquet P, Vargaftig BB.
    Eur J Pharmacol; 1986 Aug 07; 127(1-2):83-95. PubMed ID: 3019727
    [Abstract] [Full Text] [Related]

  • 5. Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions.
    Jancar S, Braquet P, Sirois P.
    Braz J Med Biol Res; 1987 Aug 07; 20(5):487-94. PubMed ID: 2838117
    [Abstract] [Full Text] [Related]

  • 6. The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis.
    Berti F, Galli G, Magni F, Rossoni G, Villa L, Puglisi L, Pasargiklian R, Braquet P.
    Pharmacol Res Commun; 1988 Dec 07; 20(12):1047-59. PubMed ID: 2463644
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
    Touvay C, Etienne A, Braquet P.
    Agents Actions; 1986 Jan 07; 17(3-4):371-2. PubMed ID: 3754380
    [Abstract] [Full Text] [Related]

  • 8. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ, Stewart AG.
    Br J Pharmacol; 1987 Apr 07; 90(4):771-83. PubMed ID: 3034369
    [Abstract] [Full Text] [Related]

  • 9. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection.
    Desquand S, Lefort J, Dumarey C, Vargaftig BB.
    Br J Pharmacol; 1991 Mar 07; 102(3):687-95. PubMed ID: 1285397
    [Abstract] [Full Text] [Related]

  • 10. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
    Ciabattoni G, Montuschi P, Currò D, Togna G, Preziosi P.
    Br J Pharmacol; 1993 May 07; 109(1):243-50. PubMed ID: 8495242
    [Abstract] [Full Text] [Related]

  • 11. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.
    Pons F, Touvay C, Lejeune V, Carré C, Vilain B, Broquet C, Mencia-Huerta JM, Braquet P.
    J Lipid Mediat; 1989 May 07; 1(6):329-40. PubMed ID: 2519901
    [Abstract] [Full Text] [Related]

  • 12. Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.
    Touvay C, Vilain B, Etienne A, Sirois P, Borgeat P, Braquet P.
    Immunopharmacology; 1986 Oct 07; 12(2):97-104. PubMed ID: 3021651
    [Abstract] [Full Text] [Related]

  • 13. Release of eicosanoids in rat peritoneal cavity during the Arthus reaction. Effect of the PAF-antagonist BN-52021 and indomethacin.
    Jancar S, Braquet P, Sirois P.
    Int J Immunopharmacol; 1989 Oct 07; 11(2):129-32. PubMed ID: 2539337
    [Abstract] [Full Text] [Related]

  • 14. Influence of the specific antagonist of PAF-acether, BN 52021, and of Ginkgo extract on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2.
    Becker K, Braquet P, Förster W.
    Biomed Biochim Acta; 1988 Oct 07; 47(10-11):S165-8. PubMed ID: 3073760
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.
    Rola-Pleszczynski M, Pignol B, Pouliot C, Braquet P.
    Biochem Biophys Res Commun; 1987 Feb 13; 142(3):754-60. PubMed ID: 3493773
    [Abstract] [Full Text] [Related]

  • 16. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction.
    Cirino M, Lagente V, Lefort J, Vargaftig BB.
    Prostaglandins; 1986 Jul 13; 32(1):121-6. PubMed ID: 3763941
    [Abstract] [Full Text] [Related]

  • 17. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
    Pretolani M, Lefort J, Malanchère E, Vargaftig BB.
    Eur J Pharmacol; 1987 Aug 21; 140(3):311-21. PubMed ID: 3653247
    [Abstract] [Full Text] [Related]

  • 18. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs.
    Koltai M, Lepran I, Szekeres L, Viossat I, Chabrier E, Braquet P.
    Eur J Pharmacol; 1986 Oct 14; 130(1-2):133-6. PubMed ID: 3780855
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
    Vilain B, Lagente V, Touvay C, Desquand S, Randon J, Lefort J, Braquet P, Vargaftig BB.
    Pharmacol Res Commun; 1986 Aug 14; 18 Suppl():119-26. PubMed ID: 3774840
    [Abstract] [Full Text] [Related]

  • 20. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021.
    Touvay C, Vilain B, Taylor JE, Etienne A, Braquet P.
    Prog Lipid Res; 1986 Aug 14; 25(1-4):277-88. PubMed ID: 2827186
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.